Viewing Study NCT04251169


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:41 PM
Study NCT ID: NCT04251169
Status: TERMINATED
Last Update Posted: 2025-06-03
First Post: 2020-01-30
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression
Sponsor: SOLTI Breast Cancer Research Group
Organization: